1. Home
  2. CLLS vs ARL Comparison

CLLS vs ARL Comparison

Compare CLLS & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cellectis S.A.

CLLS

Cellectis S.A.

HOLD

Current Price

$4.75

Market Cap

485.6M

Sector

Health Care

ML Signal

HOLD

Logo American Realty Investors Inc.

ARL

American Realty Investors Inc.

HOLD

Current Price

$15.98

Market Cap

258.1M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLLS
ARL
Founded
1999
1999
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
485.6M
258.1M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
CLLS
ARL
Price
$4.75
$15.98
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
112.6K
1.3K
Earning Date
11-07-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.36
Revenue
$82,551,000.00
$49,060,000.00
Revenue This Year
$32.58
N/A
Revenue Next Year
$20.68
N/A
P/E Ratio
N/A
$44.81
Revenue Growth
129.04
N/A
52 Week Low
$1.10
$9.43
52 Week High
$5.48
$17.00

Technical Indicators

Market Signals
Indicator
CLLS
ARL
Relative Strength Index (RSI) 54.48 52.01
Support Level $4.47 $15.45
Resistance Level $5.03 $16.60
Average True Range (ATR) 0.28 0.32
MACD -0.02 0.04
Stochastic Oscillator 54.55 61.25

Price Performance

Historical Comparison
CLLS
ARL

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

Share on Social Networks: